Recursion Pharmaceuticals had a revenue of 4.51M in the quarter ending Dec 31, 2024, with -82.70%. This bring the company's revenue in the last twelve months to 58.80M, Increased -9.79%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.